AGIOS PHARMACEUTICALS, INC. Capital Expenditures
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Capital Expenditures of $1.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.21M, a 38.51% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $769.00K, a 0.39% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.12M, a 15.82% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.55M, a 271.12% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $4.32M, a 156.14% increase from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $1.69M, a 68.67% increase from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $999.00K, a 79.53% decline from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $4.88M, a 14.98% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.98M 10-Q · filed 2026-07-30 | $3.10M derived: sum of 3 quarters · filed 2026-07-30 | $4.66M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $769.00K 10-Q · filed 2026-04-29 | $1.89M derived: sum of 2 quarters · filed 2026-04-29 | $3.44M derived: sum of 3 quarters · filed 2026-04-29 | $4.32M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.67M derived: sum of 2 quarters · filed 2026-02-12 | $3.55M derived: sum of 3 quarters · filed 2026-07-30 | $4.32M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.43M derived: sum of 2 quarters · filed 2026-07-30 | $3.20M 10-Q · filed 2025-10-30 | $4.16M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $875.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.64M 10-Q · filed 2026-07-30 | $2.61M derived: sum of 3 quarters · filed 2026-07-30 | $3.03M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $766.00K 10-Q · filed 2026-04-29 | $1.73M derived: sum of 2 quarters · filed 2026-04-29 | $2.15M derived: sum of 3 quarters · filed 2026-04-29 | $2.31M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $967.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.39M derived: sum of 2 quarters · filed 2026-02-12 | $1.54M derived: sum of 3 quarters · filed 2026-02-12 | $1.69M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $577.00K derived: sum of 2 quarters · filed 2025-10-30 | $718.00K 10-Q · filed 2025-10-30 | $952.00K derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $299.00K 10-Q · filed 2025-07-31 | $533.00K derived: sum of 3 quarters · filed 2026-02-12 | $902.00K derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $141.00K 10-Q · filed 2025-05-01 | $375.00K derived: sum of 2 quarters · filed 2026-02-12 | $744.00K derived: sum of 3 quarters · filed 2026-02-12 | $741.00K derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $603.00K derived: sum of 2 quarters · filed 2026-02-12 | $600.00K derived: sum of 3 quarters · filed 2026-02-12 | $999.00K 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $366.00K derived: sum of 2 quarters · filed 2024-10-31 | $765.00K 10-Q · filed 2024-10-31 | $878.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $396.00K 10-Q · filed 2024-08-01 | $509.00K derived: sum of 3 quarters · filed 2025-02-13 | $547.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $399.00K 10-Q · filed 2024-05-02 | $512.00K derived: sum of 2 quarters · filed 2025-02-13 | $550.00K derived: sum of 3 quarters · filed 2025-02-13 | $2.48M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $151.00K derived: sum of 2 quarters · filed 2025-02-13 | $2.08M derived: sum of 3 quarters · filed 2025-02-13 | $4.88M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.96M derived: sum of 2 quarters · filed 2023-11-02 | $4.77M 10-Q · filed 2023-11-02 | $9.27M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.73M 10-Q · filed 2023-08-03 | $9.23M derived: sum of 3 quarters · filed 2024-02-15 | $9.21M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $2.80M 10-Q · filed 2023-05-04 | $7.31M derived: sum of 2 quarters · filed 2024-02-15 | $7.28M derived: sum of 3 quarters · filed 2024-02-15 | $7.53M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $4.48M derived: sum of 2 quarters · filed 2024-02-15 | $4.73M derived: sum of 3 quarters · filed 2024-02-15 | $5.74M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $227.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.24M 10-Q · filed 2022-11-03 | $1.80M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.26M 10-Q · filed 2022-08-04 | $1.82M derived: sum of 3 quarters · filed 2023-02-23 | $7.03M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $1.01M 10-Q · filed 2022-05-05 | $1.57M derived: sum of 2 quarters · filed 2023-02-23 | $6.78M derived: sum of 3 quarters · filed 2023-02-23 | $10.92M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.77M derived: sum of 2 quarters · filed 2023-02-23 | $9.91M derived: sum of 3 quarters · filed 2023-02-23 | $14.11M 10-K · filed 2023-02-23 | $14.91M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $9.35M derived: sum of 2 quarters · filed 2021-11-03 | $13.54M 10-Q · filed 2021-11-03 | $13.89M 10-Q · filed 2020-11-05 | $20.23M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $4.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $8.34M 10-Q · filed 2021-07-29 | $8.69M 10-Q · filed 2020-07-30 | $15.02M derived: sum of 3 quarters · filed 2022-02-24 | $17.06M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $4.20M 10-Q · filed 2021-04-29 | $4.46M 10-Q · filed 2020-04-30 | $10.88M derived: sum of 2 quarters · filed 2022-02-24 | $12.91M derived: sum of 3 quarters · filed 2022-02-24 | $14.19M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $6.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $8.72M derived: sum of 2 quarters · filed 2022-02-24 | $9.99M derived: sum of 3 quarters · filed 2022-02-24 | $12.03M 10-K · filed 2022-02-24 | $12.17M 10-K · filed 2020-02-19 | |||
| 2019-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.31M derived: sum of 2 quarters · filed 2020-11-05 | $5.35M 10-Q · filed 2020-11-05 | $6.40M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $3.31M 10-Q · filed 2020-07-30 | $4.36M derived: sum of 3 quarters · filed 2021-02-25 | $7.50M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.04M 10-Q · filed 2020-04-30 | $3.09M derived: sum of 2 quarters · filed 2021-02-25 | $6.23M derived: sum of 3 quarters · filed 2021-02-25 | $7.59M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.19M derived: sum of 2 quarters · filed 2021-02-25 | $5.55M derived: sum of 3 quarters · filed 2021-02-25 | $6.99M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $3.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $4.50M derived: sum of 2 quarters · filed 2019-10-31 | $5.93M 10-Q · filed 2019-10-31 | $7.21M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.79M 10-Q · filed 2019-08-01 | $4.07M derived: sum of 3 quarters · filed 2020-02-19 | $6.09M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $1.43M 10-Q · filed 2019-05-02 | $2.71M derived: sum of 2 quarters · filed 2020-02-19 | $4.73M derived: sum of 3 quarters · filed 2020-02-19 | $5.77M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $3.30M derived: sum of 2 quarters · filed 2020-02-19 | $4.33M derived: sum of 3 quarters · filed 2020-02-19 | $4.63M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $3.05M derived: sum of 2 quarters · filed 2018-11-01 | $3.35M 10-Q · filed 2018-11-01 | $4.57M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.33M 10-Q · filed 2018-08-02 | $2.55M derived: sum of 3 quarters · filed 2019-02-14 | $5.98M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-03-31 | $293.00K 10-Q · filed 2018-05-04 | $1.51M derived: sum of 2 quarters · filed 2019-02-14 | $4.94M derived: sum of 3 quarters · filed 2019-02-14 | $7.67M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2016-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $4.65M derived: sum of 2 quarters · filed 2019-02-14 | $7.38M derived: sum of 3 quarters · filed 2019-02-14 | $9.91M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $6.16M derived: sum of 2 quarters · filed 2017-11-01 | $8.69M 10-Q · filed 2017-11-01 | $10.88M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $5.27M 10-Q · filed 2017-08-08 | $7.45M derived: sum of 3 quarters · filed 2018-02-14 | $10.75M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-03-31 | $2.53M 10-Q · filed 2017-05-04 | $4.72M derived: sum of 2 quarters · filed 2018-02-14 | $8.02M derived: sum of 3 quarters · filed 2018-02-14 | $18.90M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2015-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $5.49M derived: sum of 2 quarters · filed 2018-02-14 | $16.37M derived: sum of 3 quarters · filed 2018-02-14 | $20.16M 10-K · filed 2018-02-14 | ||||
| 2015-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $14.18M derived: sum of 2 quarters · filed 2016-11-03 | $17.98M 10-Q · filed 2016-11-03 | $19.47M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $10.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $14.68M 10-Q · filed 2016-08-08 | $16.17M derived: sum of 3 quarters · filed 2017-02-16 | $16.80M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $3.80M 10-Q · filed 2016-05-09 | $5.29M derived: sum of 2 quarters · filed 2017-02-16 | $5.91M derived: sum of 3 quarters · filed 2017-02-16 | $6.00M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $2.12M derived: sum of 2 quarters · filed 2017-02-16 | $2.20M derived: sum of 3 quarters · filed 2017-02-16 | $2.22M 10-K · filed 2017-02-16 | ||||
| 2014-09-30 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $714.00K derived: sum of 2 quarters · filed 2015-11-06 | $727.00K 10-Q · filed 2015-11-06 | $946.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $99.00K 10-Q · filed 2015-08-07 | $318.00K derived: sum of 3 quarters · filed 2016-02-26 | $417.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $13.00K 10-Q · filed 2015-05-11 | $232.00K derived: sum of 2 quarters · filed 2016-02-26 | $331.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.03M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $318.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.02M derived: sum of 3 quarters · filed 2016-02-26 | $1.29M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $800.00K derived: sum of 2 quarters · filed 2014-11-07 | $1.07M 10-Q · filed 2014-11-07 | $1.10M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $976.00K 10-Q · filed 2014-08-07 | $1.00M derived: sum of 3 quarters · filed 2015-02-24 | $2.14M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $275.00K 10-Q · filed 2014-05-09 | $301.00K derived: sum of 2 quarters · filed 2015-02-24 | $1.44M derived: sum of 3 quarters · filed 2015-02-24 | |||||
| 2012-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $1.17M derived: sum of 2 quarters · filed 2015-02-24 | $1.48M 10-K · filed 2015-02-24 | |||||
| 2012-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.45M 10-Q · filed 2013-11-07 | ||||||
| 2012-06-30 | $308.00K 10-Q · filed 2013-09-05 | |||||||
| 2011-12-31 | $1.91M 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |